Cyproterone acetate in the treatment of oestrogen hypersensitivity vulvovaginitis

@article{Nguyen2018CyproteroneAI,
  title={Cyproterone acetate in the treatment of oestrogen hypersensitivity vulvovaginitis},
  author={Yvonne Nguyen and J. Bradford and G. Fischer},
  journal={Australasian Journal of Dermatology},
  year={2018},
  volume={59}
}
  • Yvonne Nguyen, J. Bradford, G. Fischer
  • Published 2018
  • Medicine
  • Australasian Journal of Dermatology
  • Oestrogen hypersensitivity vulvovaginitis is a rare chronic cyclical vulvovaginitis responsive to oestrogen suppression or antagonism. We present a case series of 16 patients with refractory cyclical vulvovaginitis, all of whom responded to oestrogen suppression with cyproterone acetate. 

    Topics from this paper.

    References

    SHOWING 1-9 OF 9 REFERENCES
    AUTOIMMUNE PROGESTERONE DERMATITIS. CURE BY OOPHORECTOMY.
    • 79
    Vulvitis attributed to hypersensitivity to estrogen. A report of 11 cases.
    • 7
    Autoimmune progesterone dermatitis: Update and insights.
    • 34
    Estrogen dermatitis.
    • 40
    • Highly Influential
    Molecular mechanisms of selective estrogen receptor modulator (SERM) action.
    • M. Dutertre, C. Smith
    • Biology, Medicine
    • The Journal of pharmacology and experimental therapeutics
    • 2000
    • 267
    • PDF
    Estrogen receptors in human nontarget tissues: biological and clinical implications.
    • 257
    Estrogen Regulates Vaginal Sensory and Autonomic Nerve Density in the Rat1
    • 93
    • PDF